(Q44997831)

English

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses (English)

1 reference

Europe PubMed Central

8 December 2017

0 references

0 references

0 references

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

biodegradable microsphere

1 reference

based on heuristic

inferred from title

Marcus Groettrup

7

object named as

Marcus Groettrup

0 references

author name string

Eva Schlosser

1

1 reference

Europe PubMed Central

8 December 2017

Marc Mueller

2

1 reference

Europe PubMed Central

8 December 2017

Stefan Fischer

3

1 reference

Europe PubMed Central

8 December 2017

Sameh Basta

4

1 reference

Europe PubMed Central

8 December 2017

Dirk H Busch

5

1 reference

Europe PubMed Central

8 December 2017

Bruno Gander

6

1 reference

Europe PubMed Central

8 December 2017

language of work or name

0 references

publication date

6 February 2008

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

26

1 reference

Europe PubMed Central

8 December 2017

1626-1637

1 reference

Europe PubMed Central

8 December 2017

13

1 reference

Europe PubMed Central

8 December 2017

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

The cross-priming pathway: a portrait of an intricate immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Cross-presentation: underlying mechanisms and role in immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Peripheral tolerance of CD8 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Regulation of phagosome maturation by signals from toll-like receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Trends in particulate antigen and DNA delivery systems for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Differences in maintenance of CD8+ and CD4+ bacteria‐specific effector‐memory T cell populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Cutting edge: rapid in vivo killing by memory CD8 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Antigenic Epitopes Fused to Cationic Peptide Bound to Oligonucleotides Facilitate Toll-Like Receptor 9-Dependent, but CD4+ T Cell Help-Independent, Priming of CD8+ T Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Pathways for antigen cross presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Phagosomes are competent organelles for antigen cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.030

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.01.030

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44997831&oldid=2139019822"